0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Vaccines against Lassa fever virus (VITAL): Phase 1 safety and immunogenicity studies of a Lassa fever vaccine, ChAdOx1 LassaJ, in healthy volunteers in the UK and Ghana [Conference Abstract] August 16, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Early dialysis and innovations for better outcome in Lassa fever patients with acute kidney injury [Conference Abstract] August 16, 2025 by Allan Mwesiga
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Hotspot mapping and vulnerability assessment to support participant recruitment for the CEPI ENABLE 1.5 Lassa fever prospective cohort study in Edo State, Nigeria [Conference Abstract] August 16, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 AI-driven early diagnosis of Lassa fever: Development of an XGBoost-Based predictive web application [Conference Abstract] August 16, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 A promising therapeutic approach for post-Lassa fever sensorineural hearing loss [Conference Abstract] August 16, 2025 by Allan Mwesiga
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Addressing misinformation, lassa fever vaccine hesitancy, and cultural barriers: developing culturally tailored communication strategies, engaging traditional and religious leaders, and countering health-related misinformation through media using Izza Community of Ebonyi State as a case study [Conference Abstract] August 16, 2025 by Esther Butamanya
